Efficacy and Safety of Momelotinib Combined With Trametinib in Adults With Metastatic KRAS-mutated Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Platinum-Based Chemotherapy Preceded by a Dose-finding Lead-in Phase

Clinical trial NCT02258607 · TERMINATED

Trial details

NCT number

NCT02258607

Sponsor

Sierra Oncology LLC - a GSK company

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2015-03-11

Primary completion

2016-07-19

Enrollment

21

View on ClinicalTrials.gov